Getting a lot of emails and comments on Biovest and Accentia.  Some suggest that I need to do more homework on the bankruptcy proceedings for these two companies, and I couldn’t agree more.  As I pointed out in the earlier post, I am uncomfortable trading this without a solid understanding of the plans of reorganization [...]

Every year about this time, the biotech and pharma world turns its focus to the annual American Society of Clinical Oncologist (ASCO).  I’m told by a few readers who concentrate in these stocks that the hit from this year’s meeting was a tiny pink sheet stock called Biovest (BVTI.PK).
Biovest presented in the plenary session of ASCO last [...]